Faiqa Munir , Manal , Saeed Ahmed , Waseem Safdar , Sayed Afzal Shah , Muhammad Kashif Maan , Raees Khan , Aman Karim
{"title":"天然牛至精油:植物化学成分、抗菌及与土霉素对抗多重耐药(MDR)细菌的协同作用","authors":"Faiqa Munir , Manal , Saeed Ahmed , Waseem Safdar , Sayed Afzal Shah , Muhammad Kashif Maan , Raees Khan , Aman Karim","doi":"10.1016/j.micpath.2025.108034","DOIUrl":null,"url":null,"abstract":"<div><div>Essential oil, particularly extracted from the aromatic plant <em>Origanum vulgare</em> (OEOs), exhibits antibacterial and anti-biofilm activity against multidrug-resistant (MDR) bacteria. In the current study, <em>Origanum vulgare</em> essential oil, a native herb of Pakistan, was tested against two novel MDR bacterial strains. These potential pathogens, isolated from the gut, have shown resistance to several antibiotics. The results indicated that the harvesting time significantly affected the oil yield, especially when the plant was collected in September 2024 during its full bloom. Extraction was performed using a modified Clevenger-type apparatus. The oil was tested against both strains: a Gram-positive bacterium, <em>Bacillus licheniformis</em>, and a Gram-negative bacterium, <em>Pseudomonas azotoformans</em>. Results demonstrated that oregano essential oil significantly inhibited the growth of both species, with a minimum inhibitory concentration of 1.25 μl/mL. The fractional inhibitory concentration index (FICI) was calculated after applying synergism using a checkerboard assay for both strains with the sensitive antibiotic oxytetracycline. <em>Bacillus licheniformis</em> exhibited a synergism value of 0.37, indicating strong synergism, whereas for <em>Pseudomonas azotoformans</em>, the FICI index was 0.50, reflecting successful synergism. This synergism helps to increase the efficacy of antibiotics and essential oils. Time-kill assays for oregano essential oil (OEO) demonstrate that within 7 h of incubation with OEO, it can completely kill Bacillus licheniformis, whereas for Pseudomonas azotoformans, the time required extends to 8 h. This approach could provide a sustainable solution for addressing the global antimicrobial resistance disease burden while also possibly reduce the economic burden for developing countries like Pakistan.</div></div>","PeriodicalId":18599,"journal":{"name":"Microbial pathogenesis","volume":"208 ","pages":"Article 108034"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Native oregano essential oil: Phytochemical composition, antibacterial and synergistic activities with oxytetracycline against multi-drug resistant (MDR) Bacteria\",\"authors\":\"Faiqa Munir , Manal , Saeed Ahmed , Waseem Safdar , Sayed Afzal Shah , Muhammad Kashif Maan , Raees Khan , Aman Karim\",\"doi\":\"10.1016/j.micpath.2025.108034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Essential oil, particularly extracted from the aromatic plant <em>Origanum vulgare</em> (OEOs), exhibits antibacterial and anti-biofilm activity against multidrug-resistant (MDR) bacteria. In the current study, <em>Origanum vulgare</em> essential oil, a native herb of Pakistan, was tested against two novel MDR bacterial strains. These potential pathogens, isolated from the gut, have shown resistance to several antibiotics. The results indicated that the harvesting time significantly affected the oil yield, especially when the plant was collected in September 2024 during its full bloom. Extraction was performed using a modified Clevenger-type apparatus. The oil was tested against both strains: a Gram-positive bacterium, <em>Bacillus licheniformis</em>, and a Gram-negative bacterium, <em>Pseudomonas azotoformans</em>. Results demonstrated that oregano essential oil significantly inhibited the growth of both species, with a minimum inhibitory concentration of 1.25 μl/mL. The fractional inhibitory concentration index (FICI) was calculated after applying synergism using a checkerboard assay for both strains with the sensitive antibiotic oxytetracycline. <em>Bacillus licheniformis</em> exhibited a synergism value of 0.37, indicating strong synergism, whereas for <em>Pseudomonas azotoformans</em>, the FICI index was 0.50, reflecting successful synergism. This synergism helps to increase the efficacy of antibiotics and essential oils. Time-kill assays for oregano essential oil (OEO) demonstrate that within 7 h of incubation with OEO, it can completely kill Bacillus licheniformis, whereas for Pseudomonas azotoformans, the time required extends to 8 h. This approach could provide a sustainable solution for addressing the global antimicrobial resistance disease burden while also possibly reduce the economic burden for developing countries like Pakistan.</div></div>\",\"PeriodicalId\":18599,\"journal\":{\"name\":\"Microbial pathogenesis\",\"volume\":\"208 \",\"pages\":\"Article 108034\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Microbial pathogenesis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0882401025007594\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial pathogenesis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0882401025007594","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Native oregano essential oil: Phytochemical composition, antibacterial and synergistic activities with oxytetracycline against multi-drug resistant (MDR) Bacteria
Essential oil, particularly extracted from the aromatic plant Origanum vulgare (OEOs), exhibits antibacterial and anti-biofilm activity against multidrug-resistant (MDR) bacteria. In the current study, Origanum vulgare essential oil, a native herb of Pakistan, was tested against two novel MDR bacterial strains. These potential pathogens, isolated from the gut, have shown resistance to several antibiotics. The results indicated that the harvesting time significantly affected the oil yield, especially when the plant was collected in September 2024 during its full bloom. Extraction was performed using a modified Clevenger-type apparatus. The oil was tested against both strains: a Gram-positive bacterium, Bacillus licheniformis, and a Gram-negative bacterium, Pseudomonas azotoformans. Results demonstrated that oregano essential oil significantly inhibited the growth of both species, with a minimum inhibitory concentration of 1.25 μl/mL. The fractional inhibitory concentration index (FICI) was calculated after applying synergism using a checkerboard assay for both strains with the sensitive antibiotic oxytetracycline. Bacillus licheniformis exhibited a synergism value of 0.37, indicating strong synergism, whereas for Pseudomonas azotoformans, the FICI index was 0.50, reflecting successful synergism. This synergism helps to increase the efficacy of antibiotics and essential oils. Time-kill assays for oregano essential oil (OEO) demonstrate that within 7 h of incubation with OEO, it can completely kill Bacillus licheniformis, whereas for Pseudomonas azotoformans, the time required extends to 8 h. This approach could provide a sustainable solution for addressing the global antimicrobial resistance disease burden while also possibly reduce the economic burden for developing countries like Pakistan.
期刊介绍:
Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports.
Research Areas Include:
-Pathogenesis
-Virulence factors
-Host susceptibility or resistance
-Immune mechanisms
-Identification, cloning and sequencing of relevant genes
-Genetic studies
-Viruses, prokaryotic organisms and protozoa
-Microbiota
-Systems biology related to infectious diseases
-Targets for vaccine design (pre-clinical studies)